1. GLP-1 Receptor Agonists: How Early Is Appropriate?

3. Goals

4. Differentiation of GLP-1-RAs

5. Antihyperglycemic Therapy in Type 2 Diabetes: General Recommendations

6. Potential Clinical Advantages of GLP-1 Receptor Agonists

7. Physiologic Effects of GLP-1 Receptor Agonists

8. Potential for GLP-1 RAs as First-Line Therapy

9. Choosing Between Agents With Low Rates of Hypoglycemia

10. Potential Clinical Disadvantages of GLP-1 Receptor Agonists

11. Potential of Once-Weekly GLP-1 Receptor Agonists: Exenatide QW

12. Combining Basal Insulin With a GLP-1 Receptor Agonist

13. Fixed Formulation

14. Once-Weekly GLP-1 RA in Combination With Basal Insulin*

15. Novel Emerging Strategies

16. Safety – Patient Education

17. Closing Comments

18. Abbreviations

19. References

20. References (cont)

21. References (cont)

22. References (cont)